- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 84.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 87.83M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 68.52M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $66.15M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $4.84M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $27.2M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $14.22M |
| Capex | Q1 2026 · Mar 31, 2026 | $2.46M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $51.54M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $8.38M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $170M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $288.46M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $280.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.41B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.47B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.18B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.38B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $15.62B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $15.64B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $18.04B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $18.1B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.52 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.44 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.52 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.44 |
| Net Income | Q1 2026 · Mar 31, 2026 | $49.98M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$29.99M |
| Revenue | Q1 2026 · Mar 31, 2026 | $196.23M |
| Revenue | Q1 2026 · Mar 31, 2025 | $124.95M |